Cogent Biosciences Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $12.1100
- Today's High:
- $12.8900
- Open Price:
- $12.7800
- 52W Low:
- $3.79
- 52W High:
- $18.07
- Prev. Close:
- $12.8200
- Volume:
- 918138
Company Statistics
- Market Cap.:
- $0.798 billion
- Book Value:
- 3.774
- Revenue TTM:
- $0.000 billion
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $-0.056 billion
- Gross Profit TTM:
- $-0.056 billion
- Profit Margin:
- 0%
- Return on Assets TTM:
- -23.7%
- Return on Equity TTM:
- -41.2%
Company Profile
Cogent Biosciences Inc had its IPO on 2018-03-29 under the ticker symbol COGT.
The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Cogent Biosciences Inc has a staff strength of 0 employees.
Stock update
Shares of Cogent Biosciences Inc opened at $12.78 at the start of the last trading session i.e. 2022-11-02.
The stocks traded within a range of $12.11 - $12.89, and closed at $12.14.
This is a -5.3% slip from the previous day's closing price.
A total volume of 918,138 shares were traded at the close of the day’s session.
In the last one week, shares of Cogent Biosciences Inc have slipped by -6.62%.
Cogent Biosciences Inc's Key Ratios
Cogent Biosciences Inc has a market cap of $0.798 billion, indicating a price to book ratio of 3.726 and a price to sales ratio of 1320.63.
In the last 12-months Cogent Biosciences Inc’s revenue was $0.000 billion with a gross profit of $-0.056 billion and an EBITDA of $-0.112 billion. The EBITDA ratio measures Cogent Biosciences Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Cogent Biosciences Inc’s operating margin was 0% while its return on assets stood at -23.7% with a return of equity of -41.2%.
In Q2, Cogent Biosciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 100%.
Cogent Biosciences Inc’s PE and PEG Ratio
- Forward PE
- -
- Trailing PE
- -
- PEG
- None
Its diluted EPS in the last 12-months stands at $-2.208 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cogent Biosciences Inc’s profitability.
Cogent Biosciences Inc stock is trading at a EV to sales ratio of 925.41 and a EV to EBITDA ratio of -6.21. Its price to sales ratio in the trailing 12-months stood at 1320.63.
Cogent Biosciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0.000 billion
- Total Liabilities
- $0.000 billion
- Operating Cash Flow
- $0.000 billion
- Capital Expenditure
- $0.000 billion
- Dividend Payout Ratio
- 0%
Cogent Biosciences Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.
Cogent Biosciences Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.
Cogent Biosciences Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.
In 1970, Cogent Biosciences Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.
Comparatively, Cogent Biosciences Inc paid $0 billion in dividends in 1970.
Other key metrics
- Current Trading Price
- $12.14
- 52-Week High
- $18.07
- 52-Week Low
- $3.79
- Analyst Target Price
- $23
Cogent Biosciences Inc stock is currently trading at $12.14 per share. It touched a 52-week high of $18.07 and a 52-week low of $18.07. Analysts tracking the stock have a 12-month average target price of $23.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Cogent Biosciences Inc
Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)
Most Active
Top Gainers
Top Losers
About
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. The company is headquartered in Cambridge, Massachusetts.